Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CSL Of Australia Faces U.S. University In Plasma Class-Action Suit

This article was originally published in PharmAsia News

Executive Summary

Australia's CSL faces an additional foe in an expanding blood-plasma class-action suit, this one a U.S. university claiming damages. The University of Utah joined the class-action suit in a U.S. district court, seeking $10 million from CSL, its CSL Behring unit and Baxter International, CSL's main competitor in the United States. The university is the first educational institution to join the suit filed by several U.S. hospitals claiming the company conspired with other plasma companies to rig markets and plasma supplies. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts